T-cell depletion with Campath-1H "in the bag" for matched related allogeneic peripheral blood stem cell transplantation is associated with reduced graft-versus-host disease, rapid immune constitution and improved survival.
We studied the outcome of 24 peripheral blood stem cell (PBSC) graft recipients, who were T-cell depleted (TCD) with either 20 mg (n = 14) or 10 mg (n = 10) Campath-1H in vitro, in comparison with a retrospective cohort of 23 unmanipulated (UM) PBSC recipients. While the neutrophil engraftment was s...
Үндсэн зохиолчид: | Chakrabarti, S, MacDonald, D, Hale, G, Holder, K, Turner, V, Czarnecka, H, Thompson, J, Fegan, C, Waldmann, H, Milligan, D |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
2003
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation.
-н: Hale, G, зэрэг
Хэвлэсэн: (1988) -
Alemtuzumab (Campath-1H) in allogeneic stem cell transplantation: where do we go from here?
-н: Chakrabarti, S, зэрэг
Хэвлэсэн: (2004) -
Campath 1 H "in the bag" is an effective method of GvHD prevention in allogeneic stem cell transplantation.
-н: Potter, M, зэрэг
Хэвлэсэн: (2000) -
COMBINED USE OF CAMPATH-1G IN-VIVO AND IN THE BAG IN ALLOGENEIC BONE-MARROW TRANSPLANTATION
-н: Fibbe, W, зэрэг
Хэвлэсэн: (1993) -
T-cell depletion of stem cell grafts with campath-1H "in the bag" followed by cyclosporin immunosuppression remains a cost effective strategy in transplantation
-н: Novitzky, N, зэрэг
Хэвлэсэн: (2004)